Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Revlimid

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Revlimid was produced by Celgene.

GSK preps filings for BCMA-targeting multiple myeloma drug

GSK preps filings for BCMA-targeting multiple myeloma drug DREAMM-2 looked at two doses of GSK2857916 in both BCMA-positive and BCMA-negative patients who had failed earlier treatment with an immuno-modulatory drug such as Celgene’s Revlimid

BMS buoyed by FDA approval of Celgene’s myelofibrosis drug

BMS buoyed by FDA approval of Celgene’s myelofibrosis drug The approval is the latest in a string of regulatory wins for Celgene, coming after approval of a combination of Revlimid (lenalidomide) and Roche’s Rituxan (rituximab) – known as the R2

Triplet approvals for myeloma boost Celgene in Q2

Triplet approvals for myeloma boost Celgene in Q2 Surge in approvals and pipeline as merger nears. Celgene has reported higher-than-expected second-quarter revenues on the back of new triple therapy approvals for myeloma blockbusters Revlimid and Pomalyst. ... Sales came in at $4.40bn, with Revlimid

Faced with regulator’s merger concerns, BMS want to offload Otezla

Faced with regulator’s merger concerns, BMS want to offload Otezla The loss of Otezla from its portfolio will be significant, though other drugs, such as flagship myeloma blockbuster Revlimid and pipeline assets such as bb2121 are more vital to the

MorphoSys eyes 2020 launch for lymphoma CAR-T challenger

MorphoSys eyes 2020 launch for lymphoma CAR-T challenger The phase 2 L-MIND study in diffuse large B-cell lymphoma (DLBCL) showed that the combination of tafasitamab with Celgene’s Revlimid (lenalidomide) had an overall response rate of 60%,

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...

Infographics